Plecanatide

What is Plecanatide?

Plecanatide is a prescription medication primarily used to treat certain chronic bowel conditions in adults. Specifically, it is indicated for the management of Irritable Bowel Syndrome with Constipation (IBS-C) and Chronic Idiopathic Constipation (CIC). Marketed under the brand name Trulance, Plecanatide belongs to a class of drugs known as guanylate cyclase-C (GC-C) agonists. It works locally in the gastrointestinal tract to help improve bowel function and alleviate associated symptoms like abdominal pain and discomfort. Unlike some other laxatives, Plecanatide has a distinct mechanism of action that targets specific receptors in the intestine, leading to increased fluid secretion and accelerated transit of stool.

How Does it Work?

The therapeutic action of Plecanatide stems from its role as a selective guanylate cyclase-C (GC-C) agonist. When ingested, Plecanatide binds to and activates GC-C receptors found on the surface of epithelial cells lining the intestine. This binding stimulates an increase in both intracellular and extracellular cyclic guanosine monophosphate (cGMP) levels. The elevated cGMP then triggers the activation of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) ion channel.

Activation of the CFTR channel leads to an increased secretion of chloride and bicarbonate into the intestinal lumen, which subsequently draws water into the bowel. This influx of fluid softens the stool and increases its volume, making it easier to pass. Furthermore, the increased fluid secretion helps to accelerate intestinal transit, reducing the time stool spends in the colon. Beyond its effects on fluid secretion and transit, Plecanatide's mechanism also contributes to a reduction in visceral pain, likely through its impact on afferent pain nerve activity. A key advantage of Plecanatide is its minimal systemic absorption, meaning it acts primarily within the gut and has a low risk of systemic side effects.

Medical Uses

Plecanatide is a valuable treatment option for adults suffering from two specific chronic bowel disorders:

• Chronic Idiopathic Constipation (CIC)

  CIC is a common condition characterized by infrequent, difficult-to-pass stools for at least three months, without an identifiable underlying cause (e.g., medication side effect, structural abnormality). Patients with CIC often experience symptoms such as straining, hard stools, and a feeling of incomplete evacuation. Plecanatide helps by increasing the frequency of spontaneous bowel movements and improving stool consistency, thereby providing significant relief from chronic constipation.

• Irritable Bowel Syndrome with Constipation (IBS-C)

  IBS-C is a subtype of Irritable Bowel Syndrome where constipation is the predominant symptom. It is characterized by recurrent abdominal pain, discomfort, and changes in bowel habits, often with infrequent and difficult bowel movements. Plecanatide not only addresses the constipation component by facilitating more regular and easier bowel movements but also significantly reduces the associated abdominal pain, a debilitating symptom for many IBS-C patients.

For both conditions, Plecanatide offers a long-term management strategy to improve overall bowel function and enhance the quality of life for affected individuals.

Dosage

The standard recommended dosage for Plecanatide (Trulance) for both Chronic Idiopathic Constipation (CIC) and Irritable Bowel Syndrome with Constipation (IBS-C) in adults is 3 mg taken orally once daily. The tablet should be swallowed whole and should not be crushed or chewed. Plecanatide can be taken with or without food, allowing for flexibility in administration. If a dose is missed, patients should take the next dose at their regular time; double dosing to make up for a missed dose is not recommended.

It is crucial to follow the prescribing physician's instructions carefully. Dosage adjustments are typically not required based on age or renal/hepatic impairment. However, Plecanatide is contraindicated in pediatric patients younger than 6 years of age due to the risk of serious dehydration, and its use is generally not recommended in patients 6 to 18 years of age.

Side Effects

Like all medications, Plecanatide can cause side effects, although not everyone experiences them. The most common side effect reported in clinical trials is diarrhea. This typically occurs early in treatment and is usually mild to moderate. If severe diarrhea develops, patients should stop taking Plecanatide and contact their healthcare provider immediately, as it could lead to dehydration. Other less common side effects may include:

• Abdominal pain
• Flatulence
• Nausea
• Upper respiratory tract infection

Serious side effects are rare but can include severe dehydration, particularly in vulnerable populations. Patients should seek immediate medical attention if they experience symptoms of an allergic reaction, such as rash, itching, swelling (especially of the face, tongue, or throat), severe dizziness, or trouble breathing. A boxed warning exists regarding the risk of serious dehydration in pediatric patients, making Plecanatide contraindicated in children under 6 years old.

Drug Interactions

Due to its minimal systemic absorption, Plecanatide has a low potential for significant drug interactions. Most of the medication remains within the gastrointestinal tract, limiting its exposure to systemic enzymes and transporters that could metabolize or interact with other drugs. However, caution should still be exercised when co-administering Plecanatide with certain other medications:

• Other Laxatives: Concomitant use with other laxatives may increase the risk or severity of diarrhea. It is generally advisable to avoid using multiple laxatives simultaneously unless specifically instructed by a healthcare provider.
• Medications Affecting Fluid and Electrolyte Balance: While Plecanatide itself has minimal systemic effects, medications that significantly alter fluid or electrolyte balance could theoretically exacerbate any fluid shifts caused by Plecanatide in cases of severe diarrhea.

It is always important to inform your doctor or pharmacist about all prescription, over-the-counter, and herbal medications, as well as any supplements you are currently taking, to ensure safe use and to identify any potential interactions.

FAQ

• Is Plecanatide a laxative?
  Yes, Plecanatide functions as a laxative by increasing fluid secretion into the intestines and accelerating stool transit, but it does so through a specific mechanism as a guanylate cyclase-C agonist rather than a bulk-forming or stimulant laxative.
• How long does Plecanatide take to work?
  Many patients experience an increase in bowel movement frequency within the first week of starting Plecanatide. However, the full benefits, including reductions in abdominal pain for IBS-C, may take a few weeks to become fully apparent.
• Can I take Plecanatide with food?
  Yes, Plecanatide can be taken with or without food, according to your preference and convenience.
• What should I do if I miss a dose?
  If you miss a dose of Plecanatide, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at once to make up for a missed dose.
• Is Plecanatide safe for children?
  No, Plecanatide is contraindicated in children younger than 6 years of age due to the risk of serious dehydration. Its use is also not recommended in pediatric patients aged 6 to 18 years.

Products containing Plecanatide are available through trusted online pharmacies. You can browse Plecanatide-based medications at ShipperVIP or Medicenter.

Summary

Plecanatide is a targeted medication offering significant relief for adults suffering from Chronic Idiopathic Constipation (CIC) and Irritable Bowel Syndrome with Constipation (IBS-C). As a guanylate cyclase-C (GC-C) agonist, it works locally in the gut to increase intestinal fluid secretion and accelerate transit, leading to more frequent, softer bowel movements and reduced abdominal pain. While diarrhea is the most common side effect, Plecanatide's minimal systemic absorption contributes to a favorable safety profile and low potential for drug interactions. Patients considering or using Plecanatide should always consult with their healthcare provider to ensure it is the appropriate treatment for their condition and to understand its proper use and potential side effects.